|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Apr 30, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Long-term investments | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and stockholders’ equity (deficit) | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Current operating lease liabilities | ||||||||||||||||||
| Current Term Loan | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Term Loan, net | ||||||||||||||||||
| Convertible Senior Notes, net | ||||||||||||||||||
| Non-current operating lease liabilities | ||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Convertible preferred stock | ||||||||||||||||||
| Total convertible preferred stock | ||||||||||||||||||
| Stockholders’ equity (deficit): | ||||||||||||||||||
| Preferred stock, $0.001 par value; 40,000,000 shares authorized, no shares issued or outstanding as of September 30, 2022 and December 31, 2021. | ||||||||||||||||||
| Common stock, $0.001 par value; 400,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 55,694,651 and 55,363,461 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively. | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||
| Total liabilities and stockholders’ equity (deficit) | ||||||||||||||||||
| Common stock, par value (in USD per share) | ||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||
| Common stock, shares outstanding (in shares) | ||||||||||||||||||
Loading...
